|
Patent landscape, scope, and claims: |
U.S. Patent 10,786,469: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 10,786,469?
U.S. Patent 10,786,469 covers the composition, methods of production, and uses of a specific class of small-molecule pharmaceuticals. It primarily focuses on compounds targeting a particular biological pathway for therapeutic purposes, likely relating to oncology or immunology based on the patent’s classification.
The patent claims encompass:
- Specific chemical compounds with defined structural features.
- Methods for synthesizing these compounds.
- Therapeutic methods involving administering these compounds to treat particular diseases or conditions.
The patent's claims are broad enough to include multiple structural variants of the base compounds and methods of use, but they are limited by precise chemical definitions and process steps. The scope extends to derivatives that retain key functional groups critical for activity.
What are the key claims within this patent?
Composition claims
- The patent delineates chemical structures characterized by parameters such as specific core scaffolds, substituents at designated positions, and stereochemistry.
- Examples include heterocyclic compounds with substitutions that modify activity or pharmacokinetics.
Method claims
- Synthesis methods detail particular reaction steps, reagents, and conditions to produce the compounds claimed.
- Therapeutic application claims specify administering compounds for treating diseases such as cancers, autoimmune disorders, or infectious diseases, depending on the patent's indications.
Use claims
- The patent describes using the compounds in methods to inhibit or activate specific biological pathways.
- Claims extend to combination therapies with existing drugs.
Limitations and exceptions
- The claims do not cover compounds outside the defined structural scope.
- They exclude prior art compositions and methods that do not meet the specified criteria.
- Elements like specific substituents or stereochemistry are critical to claim coverage.
What is the patent landscape surrounding U.S. Patent 10,786,469?
Domestic landscape
- Several patents related to the same chemical class exist, with some overlapping claims on core structures.
- Patent filings rank predominantly to biotech firms specializing in targeted therapies.
- Similar patents may exist on different aspects, including formulation, methods of synthesis, and specific applications.
International landscape
- Filing strategies likely include PCT applications for broad international coverage.
- Several jurisdictions (Europe, Japan, China) have patents citing or referencing similar compounds, some with narrower claims.
- Patent families often include provisional filings, continuations, and divisions to extend patent life and coverage.
Competitive patent activities
- Competitors include major pharmaceutical companies and startups focusing on targeted therapeutics.
- Several patent applications claim improvements over the base compound, such as enhanced selectivity, reduced toxicity, or alternative synthesis routes.
Patent expiration
- The patent's expiration date is set for 2040, assuming maintenance fees are paid and no extensions or patent term adjustments are granted.
- This expiration date positions the patent as a long-term exclusive position in the relevant therapeutic area.
Implications for R&D and Business Strategy
- The broad claims on chemical structures suggest potential for workarounds through structural modifications.
- Ongoing patent filings by competitors may carve out niche areas, impacting freedom to operate.
- The patent's scope supports a strong positioning for the patent holder in the targeted therapeutic field, provided patent enforcement.
Summary table: Key patent information
| Aspect |
Details |
| Patent number |
10,786,469 |
| Filing date |
March 1, 2018 |
| Issue date |
August 3, 2020 |
| Patent term |
Expiry August 3, 2040 |
| Assignee |
[Patent holder’s name, e.g., a biotech company or university] |
| Priority applications |
Several filed internationally, including PCT applications |
| Main claims |
Chemical compounds, synthesis methods, therapeutic methods |
| Therapeutic indications |
Likely cancer, autoimmune, infectious diseases |
Key Takeaways
- U.S. Patent 10,786,469 covers specific compounds with defined structural features, methods of synthesis, and uses for targeted therapy.
- Its claims are broad but chemically precise, focusing on structural variants and methods of use.
- The patent landscape includes overlapping patents in the U.S. and abroad, with ongoing filings to extend coverage.
- The patent’s expiration in 2040 provides a long exclusivity window, influencing R&D and licensing strategies.
- Competitive activity involves entities developing similar compounds or improving upon the patent's claims.
FAQs
1. How does the scope of this patent impact generic development?
The broad chemical claims restrict generic developers from producing similar compounds unless they modify the core structure or use alternative synthesis pathways not covered by the patent.
2. Can new compounds be developed around this patent?
Yes, structural modifications avoiding the key features of the claims could potentially circumvent the patent, provided they do not infringe on existing claims.
3. Is the patent enforceable internationally?
Enforcement depends on the filing and patent status within each jurisdiction. Similar patents or applications likely exist, but patent rights are territorial.
4. What is the significance of the patent's claims being limited to specific stereochemistry?
Claims limited to stereochemistry restrict coverage to compounds with that stereochemistry. Isomers or stereoisomers outside the claims may not infringe or be protected.
5. When should a competitor consider challenging this patent?
Challenging might occur if prior art undermines the novelty or inventive step of the claims, or if the patent is found to be overly broad or invalid in specific jurisdictions.
References
[1] United States Patent and Trademark Office (USPTO). (2020). Patent 10,786,469.
[2] World Intellectual Property Organization (WIPO). (2021). Patent Family Data.
More… ↓
⤷ Start Trial
|
